Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer's disease model by modulating BDNF signaling pathway

Journal of Cellular Biochemistry

Volumn 114, Issue 10, 2013, Pages 2209-2220

  Cimini, Annamaria ^a,b   Gentile, Roberta ^a   D'Angelo, Barbara ^a   Benedetti, Elisabetta ^a   Cristiano, Loredana ^a   Avantaggiati, Maria Laura ^c   Giordano, Antonio ^b,d   Ferri, Claudio ^a   Desideri, Giovambattista ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Temple University   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d UNIVERSITY OF SIENA   (Italy)

Author keywords

ANTI OXIDANT; BDNF SIGNALING; CYTOSKELETRIC PROTEINS; NEURITES; NEURODEGENERATIVE DISEASES; NEURONS

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; BRAIN DERIVED NEUROTROPHIC FACTOR; FLAVONOID; OLIGOMER; POLYPHENOL DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CACAO; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE DEGENERATION; NEURITE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 84882314243     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24548     Document Type: Article

References (56)

1. Baron-Menguy C, Bocquet A, Guihot AL, Chappard D, Amiot MJ, Andriantsitohaina R, Loufrani L, Henrion D,. 2007. Effects of red wine polyphenols on postischemic neovascularization model in rats: Low doses are proangiogenic, high doses anti-angiogenic. FASEB J 21: 3511-3521.
2. Bravo L,. 1998. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56: 317-333.
3. Choi YT, Jung CH, Lee SR, Bae JH, Baek WK, Suh MH, Park J, Park CW, Suh SI,. 2001. The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci 70: 603-614.
4. Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ,. 2006. ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 281: 20315-20325.
5. Christen Y,. 2000. Oxidative stress and Alzheimer disease. Am J Clin Nutr 71: 621S-629S.
6. Cimini A, Moreno S, D'Amelio M, Cristiano L, D'Angelo B, Falone S, Benedetti E, Carrara P, Fanelli F, Cecconi F, Amicarelli F, Cerù MP,. 2009a. Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer disease. A role for peroxisomes. J Alzheimers Dis 18: 935-952.
7. Cimini A, Benedetti E, D'Angelo B, Cristiano L, Falone S, Di Loreto S, Amicarelli F, Cerù MP,. 2009b. Neuronal response of peroxisomal and peroxisome-related proteins to chronic and acute Aβ injury. Curr Alzh Res 6: 238-250.
8. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF,. 2000. Intake of flavonoids and risk of dementia. Eur J Epidemiol 16: 357-363.
9. D'Angelo B, Santucci S, Benedetti E, Di Loreto S, Phani RA, Falone S, Amicarelli F, Cerù MP, Cimini A,. 2009. Cerium oxide nanoparticles trigger neuronal survival in a human alzheimer disease model by modulating BDNF pathway current nanoscience Curr Nanosci 5: 167-176.
10. Dajas F, Rivera F, Blasina F, Arredondo F, Echeverry C, Lafon L, Morquio A, Heizen H,. 2003. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox Res 5: 425-432.
11. de Rijk MC, Breteler MM, den Breeijen JH, Launer LJ, Grobbee DE, van der Meché FG, Hofman A,. 1997. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol 54: 762-765.
12. Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM,. 2001. Nutritional factors in cerebral aging and dementia: Epidemiological arguments for a role of oxidative stress. Neuroepidemiology 220: 7-15.
13. Desideri G, Kwik-Uribe C, Grassi D, Necozione S, Ghiadoni L, Mastroiacovo D, Raffaele A, Ferri L, Bocale R, Lechiara MC, Marini C, Ferri C,. 2012. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: The Cocoa, Cognition, and Aging (CoCoA) study. Hypertension 60: 794-801.
14. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM,. 2002. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287: 3223-3229.
15. Fu Y, Koo MW,. 2006. EGCG protects HT-22 cells against glutamate-induced oxidative stress. Neurotox Res 10: 23-30.
16. Guedj F, Sébrié C, Rivals I, Ledru A, Paly E, Bizot JC, Smith D, Rubin E, Gillet B, Arbones M, Delabar JM,. 2009. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS ONE 4: e4606
17. Hammerstone JF, Lazarus SA, Schmitz HH,. 2000. Procyanidin content and variation in some commonly consumed foods. J Nutr 130: 2086S-2092S.
18. Haque AM, Hashimoto M, Katakura M, Hara Y, Shido O,. 2008. Green tea catechins prevent cognitive deficits caused by Abeta 1-40 in rats. J Nutr Biochem 19: 619-626.
19. Heo HJ, Lee CY,. 2005. Epicatechin and catechin in cocoa inhibit amyloid β protein induced apoptosis. J Agric Food Chem 53: 1445-1448.
20. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J,. 1996. Acetylcholinesterase accelerates assembly of amyloid- beta-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme. Neuron 16: 881-891.
21. Jenner P,. 1996. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathol Biol 44: 57-64.
22. Joseph JA, Shukitt-Hale B, Casadesus G,. 2005. Reversing the deleterious effects of aging on neuronal communication and behavior: Beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr 81: 313S-316S.
23. Kim J, Lee HJ, Lee KW,. 2010. Naturally occurring phytochemicals for the prevention of Alzheimer's Disease. J Neurochem 112: 1415-1430.
24. Lamuela-Ravento's RM, Andre's-Lacueva C, Permanyer J, Izquierdo-Pulido M,. 2001. More antioxidants in cocoa. J Nutr 131: 834.
25. Lee K. W, Kim YJ, Lee HJ, Lee CY,. 2003. Cocoa has more phenoloc phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem 51: 7292-7295.
26. Lovell MA, Ehmann WD, Butler SM, Markesbery WR,. 1995. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45: 1594-1601.
27. Manach C, Donovan JL,. 2004. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 38: 771-785.
28. Mandel S, Youdim MB,. 2004. Catechin polyphenols: Neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37: 304-317.
29. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML,. 1998. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150: 40-44.
30. Markesbery WR,. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147.
31. Munõz FJ, Inestrosa NC,. 1999. Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes. FEBS Lett 450: 205-209.
32. Naiki H, Higuchi K, Nakakuki K, Takeda T,. 1991. Kinetic analysis of amyloid fibril polymerization. Lab Invest 65: 104-110.
33. Noe' V, PenËœuelas S, Lamuela-Ravento's RS, Permanyer J, Ciudad CJ, Izquierdo-Pulido M,. 2004. Epicatechin and a cocoa polyphenolic extract modulate gene expression in human Caco-2. Cells J Nutr 134: 2509-2516.
34. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA,. 1999. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19: 1959-1964.
35. Oken BS, Storzbach DM, Kaye JA,. 1998. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55: 1409-1415.
36. Rahman K,. 2007. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 22: 219-236.
37. Ramassamy C,. 2006. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets. Eur J Pharmacol 545: 51-64.
38. Rice-Evans C,. 2001. Flavonoid antioxidants. Curr Med Chem 8: 797-807.
39. Ross JA, Kasum CM,. 2002. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu Rev Nutr 22: 19-34.
40. Santos MJ, Quintanilla RA, Toro A, Grandy R, Dinamarca MC, Godoy JA, Inestrosa NC,. 2005. Peroxisomal proliferation protects from β-Amyloid neurodegeneration. J Biol Chem 80: 41057-41068.
41. Sayre LM, Zagorski MG, Surewicz WK, Krafft GA, Perry G,. 1997. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: A critical appraisal. Chem Res Toxicol 10: 518-526.
42. Schroeter H, Bahia P, Spencer JP, Sheppard O, Rattray M, Cadenas E, Rice-Evans C, Williams RJ,. 2007. (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem 101: 1596-1606.
43. Selkoe DJ,. 2002. Alzheimer's disease is a synaptic failure. Science 298: 789-791.
44. Selkoe DJ,. 2004. Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6: 1054-1061.
45. Simonyi A, Wang Q, Miller RL, Yusof M, Shelat PB, Sun AY, Sun GY,. 2005. Polyphenols in cerebral ischemia: Novel targets for neuroprotection. Mol Neurobiol 31: 135-147.
46. Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C,. 2008. Challenges for research on polyphenols from foods in Alzheimer's disease: Bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric Food Chem 56: 4855-4873.
47. Smith MA, Tabaton M, Perry G,. 1996. Early contribution of oxidative glycation in Alzheimer disease. Neurosci Lett 217: 210-211.
48. Steinberg FM, Bearden MM, Keen CL,. 2003. Cocoa and chocolate flavonoids: Implications for cardiovascular health. J Am Diet Assoc 103: 215-223.
49. Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD, Kermani P, Torkin R, Chen ZY, Lee FS, Kraemer RT, Nykjaer A, Hempstead BL,. 2005. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 25: 5455-5463.
50. Varadarajan S, Yatin S, Aksenova M, Butterfield DA,. 2000. Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130: 184-208.
51. Varadarajan S, Kanski J, Aksenova M,. 2001. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1-42) and Aβ (25-35). J Am Chem Soc 123: 5625-5631.
52. Walsh DM, Selkoe DJ,. 2007. A beta oligomers-A decade of discovery. J.Neurochem 101: 1172-1184.
53. Waterhouse AL, Shirley JR, Donovan JL,. 1996. Antioxidants in chocolate. Lancet 348: 834.
54. White JA, Manelli AM, Holmberg KH, Van Eldik LJ, Ladu MJ,. 2005. Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. Neurobiol Dis 18: 459-465.
55. Williams RJ, Spencer JP,. 2012. Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 52: 35-45.
56. Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ,. 1989. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14: 175-185.